VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report)’s share price was up 36.4% during trading on Saturday . The company traded as high as C$0.17 and last traded at C$0.15. Approximately 1,722,555 shares traded hands during trading, an increase of 726% from the average daily volume of 208,641 shares. The stock had previously closed at C$0.11.
VentriPoint Diagnostics Stock Performance
The stock’s 50-day simple moving average is C$0.13 and its 200 day simple moving average is C$0.12. The company has a debt-to-equity ratio of -58.56, a quick ratio of 6.67 and a current ratio of 0.28. The company has a market cap of C$24.33 million, a PE ratio of -4.63 and a beta of 0.39.
VentriPoint Diagnostics Company Profile
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
See Also
- Five stocks we like better than VentriPoint Diagnostics
- What is Insider Trading? What You Can Learn from Insider Trading
- RH Stock Rockets on Surprise Profit and Tariff Shift
- Why Invest in High-Yield Dividend Stocks?
- Synopsys Stock Falls on China Ban, But Long-Term Outlook Holds
- How to Invest in Insurance Companies: A Guide
- Alphabet Enters a Bull Market: Is It Time to Buy?
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
